All News Rafarma Pharmaceuticals, Inc.

Equities

RAFA

US75062C1009

Delayed OTC Markets Other stock markets 09:44:25 15/05/2024 pm IST			5-day change	1st Jan Change
0.11 ^USD	-12.00%		+22.22%	-57.90%

2021	RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	CI
2021	Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University	11/12	AQ
Rafarma Pharmaceutical news update	30/11	AQ
Rafarma Pharmaceuticals : RAFA Financials Q2	15/22/15	PU
Rafarma Pharmaceuticals strengthens its position in Central Asia	29/22/29	AQ
Rafarma’s Slavich Noya Technology Division Expands Printing Production	07/22/07	AQ
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research	21/21/21	AQ
RAFA To Add Major Component to the Tashkent Pharma Park	17/21/17	AQ
RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	17/21/17	CI
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5	19/21/19	AQ
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs	19/21/19	GL
Letter to Shareholders from the Chairman of the Board Ilya Shpurov	10/21/10	GL
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build	30/21/30	GL
Rafarma’s Global Pharmaceutical Strategy At A Glance	18/21/18	GL
Rafarma To Expand Proton Therapy Centers	07/21/07	GL
Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers	07/21/07	CI
Rafarma and Haifa Technopark Enter Talks for Joint Venture	30/21/30	GL
Rafarma Embarks on Aggressive Global Partnerships Plan	04/21/04	GL
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	29/21/29	GL
Rafarma Pharmaceuticals, Inc. Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	29/21/29	CI
Vaccines Lab Sdn Bhd Enters Master Strategic Joint Venture Agreement with Rafarma Pharmaceuticals Inc	15/20/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Rafarma Pharmaceuticals, Inc.

Equities

RAFA

US75062C1009

All News

Filters